Illumina Ventures raises $325M to fund health startups

By The Science Advisory Board staff writers

September 20, 2021 -- Illumina Ventures has raised $325 million for its second investment fund, which will support healthcare startups.

With the latest round of investments, Illumina Ventures has built up a genomic-focused fund of $560 million. The money will support early-stage companies that are developing life science tools, clinical diagnostics, and therapeutics platforms, as well as digital health and other genomics applications.

Illumina Ventures is an independently managed investment firm. Funding for the second fund is anchored by an investment from Illumina, with the rest committed by other strategic and financial advisors.


Copyright © 2021 scienceboard.net
 

Create an Account

Already have an account? Sign in Here

To access all ScienceBoard content create a free account now:



Email Address:  

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

 
I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.

Email Preferences



Letter from the Editor Please send me twice-weekly roundups of all the latest life research and industry news.
SAB Announcements Please send me the latest announcements from The Science Advisory Board and their partners.
Spotlight Receive notifications about new content, services, or educational resources designed to help you sharpen your skills and grow professionally.